Miranda Schmalfuhs

Miranda Schmalfuhs is the associate group social media editor of Pharmaceutical Executive, Pharmaceutical Commerce, and Applied Clinical Trials and can be reached at mschmalfuhs@mjhlifesciences.com.

Articles by Miranda Schmalfuhs

Pharma Pulse 11/26/24: RFID Technological Obstacles, Self-Care for the Flu & more

ByMiranda Schmalfuhs

November 26th 2024

The latest news for pharma industry insiders.

Pharma Pulse 11/25/24: Deepening Patient Relationships, Menopause May Increase Risk of Asthma & more

ByMiranda Schmalfuhs

November 25th 2024

The latest news for pharma industry insiders.

Pharma Pulse 11/22/24: Challenges Facing the Pharma Industry in 2025 & more

ByMiranda Schmalfuhs

November 22nd 2024

The latest news for pharma industry insiders.

Pharma Pulse 11/21/24: A Global Standard for Data Sources, 75% of Adults are Obese & more

ByMiranda Schmalfuhs

November 21st 2024

The latest news for pharma industry insiders.

Pharma Pulse 11/20/24: Impact of ALZ on Heath Equity, Seasonal Flu Returns to Pre-Pandemic Levels, & More

ByMiranda Schmalfuhs

November 20th 2024

The latest news for pharma industry insiders.

Pharma Pulse 11/19/24: Is Any Data Better Than No Data? Exploring Emerging Vitiligo Therapies & more

ByMiranda Schmalfuhs

November 19th 2024

The latest news for pharma industry insiders.

Pharma Pulse 11/18/24: An Overview of RFID, Moving More Modifies Mood & more

ByMiranda Schmalfuhs

November 18th 2024

The latest news for pharma industry insiders.

Pharma Pulse 11/15/24: SARS-CoV-2 Infection Impact Child Neurodevelopment, History of ED Increases Risk of Psychiatric Disorders for Children & more

ByMiranda Schmalfuhs

November 15th 2024

The latest news for pharma industry insiders.

Pharma Pulse 11/14/24: Global Disparities in Cancer Burden, What Happens if Millions Lose Access to GLP-1s & more

ByMiranda Schmalfuhs

November 14th 2024

The latest news for pharma industry insiders.

Pharma Pulse 11/13/24: FDA's Exemption for DSCSA Compliance, Pharmacists Combat Flu Misinformation and Expand Vaccine Access & more

ByMiranda Schmalfuhs

November 13th 2024

The latest news for pharma industry insiders.

Pharma Pulse 11/12/24: Takeaways From Midlife MS Patients, The Power of Simplicity for First-in-Human Studies & more

ByMiranda Schmalfuhs

November 12th 2024

The latest news for pharma industry insiders.

Pharma Pulse 11/11/24: The Importance of Improving DE&I in Clinical Trials, Financial Toxicity About More Than Just Affording Treatment & more

ByMiranda Schmalfuhs

November 11th 2024

The latest news for pharma industry insiders.

Pharma Pulse 11/8/24: Dusting Off One’s Cost Center Hat, Iron Supplements Benefit Children with HIV & more

ByMiranda Schmalfuhs

November 8th 2024

The latest news for pharma industry insiders.

Advertising/Marketing Trends to Expect in Q1 of 2025

ByMiranda Schmalfuhs

November 8th 2024

Ted Sweetser, VP, Ad Partnerships and Strategy, PurpleLab, identifies advertising/marketing trends he expects in Q1 of 2025.

Healthcare Serving as a Roadmap for Other Sectors

ByMiranda Schmalfuhs

November 7th 2024

Ted Sweetser, VP, Ad Partnerships and Strategy, PurpleLab explains how the healthcare industry's experience with privacy-compliant targeting can serve as a roadmap for other sectors.

Pharma Pulse 11/7/24: Women Within Health Care Face Financial Disparities, The New Frontier for Clinical Research Excellence & more

ByMiranda Schmalfuhs

November 7th 2024

The latest news for pharma industry insiders.

Potential Implications of Phasing-Out Cookies

ByMiranda Schmalfuhs

November 6th 2024

Ted Sweetser, VP, Ad Partnerships and Strategy, PurpleLab explored the potential implications of the phase-out of cookies for the broader advertising industry.

Experts Weigh-In on Compounded GLP-1/Semaglutide Solution

ByMiranda Schmalfuhs

November 6th 2024

Industry experts comment on the increasing popularity of compounded medications, particularly GLP-1s, due to drug shortages and the desire for personalized treatments.

Pharma Pulse 11/6/24: Enacting Sustainable Practices, Pharmacist Provider Status Is Growing & more

ByMiranda Schmalfuhs

November 6th 2024

The latest news for pharma industry insiders.

Pharma Pulse 11/5/24: FDA’s Diversity Action Plan Guidance, Combatting Medical Misinformation & more

ByMiranda Schmalfuhs

November 5th 2024

The latest news for pharma industry insiders.

Balancing Personalized Targeting with Protecting Consumer Privacy

ByMiranda Schmalfuhs

November 5th 2024

Ted Sweetser, VP, Ad Partnerships and Strategy, PurpleLab discusses the need to balance personalized targeting with the ethical imperative to protect consumer privacy.

Promising Alternative Targeting Methods in a Post-Cookie World

ByMiranda Schmalfuhs

November 4th 2024

Ted Sweetser, VP, Ad Partnerships and Strategy, PurpleLab explores the most promising alternative targeting methods that advertisers can adopt in a post-cookie world, and how they compare to traditional approaches.

Pharma Pulse 11/4/24: Community Pharmacies in Crisis, Insights Into ADHD Diagnoses in Adult Women & more

ByMiranda Schmalfuhs

November 4th 2024

The latest news for pharma industry insiders.

Pharma Pulse 11/1/24: Navigating Diversity and Digital Innovation, Key Clinical Information on Infertility & more

ByMiranda Schmalfuhs

November 1st 2024

The latest news for pharma industry insiders.

Key Benefits of RWD in Privacy and Targeting Effectiveness

ByMiranda Schmalfuhs

November 1st 2024

Ted Sweetser, VP, Ad Partnerships and Strategy, PurpleLab discussed how the use of Real-World Data has evolved in the healthcare industry in terms of privacy and targeting effectiveness.

Effectively Targeting Patients Without Cookies

ByMiranda Schmalfuhs

October 31st 2024

Ted Sweetser, VP, Ad Partnerships and Strategy, PurpleLab explored how healthcare advertisers have been able to effectively target patients without relying heavily on traditional tracking methods.

Pharma Pulse 10/31/24: Did Vampire Myths Originate From a Blood Disorder? Solving Payment Challenges at the Site-Level & more

ByMiranda Schmalfuhs

October 31st 2024

The latest news for pharma industry insiders.

Addressing Supply Chain Challenges & Improving Patient Access

ByMiranda Schmalfuhs

October 30th 2024

Scott Brunner, CEO, and Tenille Davis, Chief Advocacy Officer, of the Alliance for Pharmacy Compounding explore solutions for the current supply chain challenges and improve patient access to medications.

Pharma Pulse 10/30/24: Connection Between Social Determinants of Health and US Healthcare Expenditures, Employers Trying To Tame Healthcare Costs & more

ByMiranda Schmalfuhs

October 30th 2024

The latest news for pharma industry insiders.

Pharma Pulse 10/29/24: Reassessing Pricing and Commercialization Approaches, Obesity Requires Pharmacotherapy, Not Just Lifestyle Interventions & more

ByMiranda Schmalfuhs

October 29th 2024

The latest news for pharma industry insiders.

Miranda Schmalfuhs

Articles by Miranda Schmalfuhs

Pharma Pulse 11/26/24: RFID Technological Obstacles, Self-Care for the Flu & more

Pharma Pulse 11/25/24: Deepening Patient Relationships, Menopause May Increase Risk of Asthma & more

Pharma Pulse 11/22/24: Challenges Facing the Pharma Industry in 2025 & more

Pharma Pulse 11/21/24: A Global Standard for Data Sources, 75% of Adults are Obese & more

Pharma Pulse 11/20/24: Impact of ALZ on Heath Equity, Seasonal Flu Returns to Pre-Pandemic Levels, & More

Pharma Pulse 11/19/24: Is Any Data Better Than No Data? Exploring Emerging Vitiligo Therapies & more

Pharma Pulse 11/18/24: An Overview of RFID, Moving More Modifies Mood & more

Pharma Pulse 11/15/24: SARS-CoV-2 Infection Impact Child Neurodevelopment, History of ED Increases Risk of Psychiatric Disorders for Children & more

Pharma Pulse 11/14/24: Global Disparities in Cancer Burden, What Happens if Millions Lose Access to GLP-1s & more

Pharma Pulse 11/13/24: FDA's Exemption for DSCSA Compliance, Pharmacists Combat Flu Misinformation and Expand Vaccine Access & more

Pharma Pulse 11/12/24: Takeaways From Midlife MS Patients, The Power of Simplicity for First-in-Human Studies & more

Pharma Pulse 11/11/24: The Importance of Improving DE&I in Clinical Trials, Financial Toxicity About More Than Just Affording Treatment & more

Pharma Pulse 11/8/24: Dusting Off One’s Cost Center Hat, Iron Supplements Benefit Children with HIV & more

Advertising/Marketing Trends to Expect in Q1 of 2025

Healthcare Serving as a Roadmap for Other Sectors

Pharma Pulse 11/7/24: Women Within Health Care Face Financial Disparities, The New Frontier for Clinical Research Excellence & more

Potential Implications of Phasing-Out Cookies

Experts Weigh-In on Compounded GLP-1/Semaglutide Solution

Pharma Pulse 11/6/24: Enacting Sustainable Practices, Pharmacist Provider Status Is Growing & more

Pharma Pulse 11/5/24: FDA’s Diversity Action Plan Guidance, Combatting Medical Misinformation & more

Balancing Personalized Targeting with Protecting Consumer Privacy

Promising Alternative Targeting Methods in a Post-Cookie World

Pharma Pulse 11/4/24: Community Pharmacies in Crisis, Insights Into ADHD Diagnoses in Adult Women & more

Pharma Pulse 11/1/24: Navigating Diversity and Digital Innovation, Key Clinical Information on Infertility & more

Key Benefits of RWD in Privacy and Targeting Effectiveness

Effectively Targeting Patients Without Cookies

Pharma Pulse 10/31/24: Did Vampire Myths Originate From a Blood Disorder? Solving Payment Challenges at the Site-Level & more

Addressing Supply Chain Challenges & Improving Patient Access

Pharma Pulse 10/30/24: Connection Between Social Determinants of Health and US Healthcare Expenditures, Employers Trying To Tame Healthcare Costs & more

Pharma Pulse 10/29/24: Reassessing Pricing and Commercialization Approaches, Obesity Requires Pharmacotherapy, Not Just Lifestyle Interventions & more

Trending on PharmExec

How Can AI Transform The Pharmaceutical Industry

Optimizing Your CGT Commercial Distribution Strategy: Four Priorities for a Successful Launch

What can Healthcare Manufacturing Learn from FDA's ANDA Prioritization Pilot?